SCHEMBL14006284

SCHEMBL14006284

CCCCOc1ccc(NC(=O)CCCCN2CCN(C)CC2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.59
GAA P10253 1/20 0.59
THRA P10827 1/20 0.58
THRB P10828 1/20 0.58
TSHR P16473 2/20 0.57
MAPT P10636 2/20 0.57
HPGD P15428 1/20 0.57
TAAR1 Q96RJ0 1/20 0.57
HSD17B10 Q99714 1/20 0.57
HRH2 P25021 2/20 0.57
HRH1 P35367 2/20 0.57
LMNA P02545 1/20 0.57
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
TP53 P04637 1/20 0.55
RAB9A P51151 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14006223 0.92 LMNA (0.68) L3MBTL1GAATHRATHRBTSHR
SCHEMBL14006202 0.91 LMNA (0.70) EPHX2L3MBTL1GAATHRATHRB
SCHEMBL14006288 0.91 LMNA (0.70) EPHX2L3MBTL1GAATHRATHRB
SCHEMBL14006285 0.90 EPHX2 (0.62) EPHX2L3MBTL1GAATSHRMAPT
SCHEMBL14006227 0.88 EPHX2 (0.65) EPHX2L3MBTL1THRBMAPTLMNA
SCHEMBL14006291 0.86 EPHX2 (0.58) EPHX2L3MBTL1GAATSHRMAPT
SCHEMBL9505612 0.82 THRB (0.63) EPHX2L3MBTL1GAATHRATHRB
SCHEMBL10638 0.79 LMNA (0.67) THRBTSHRMAPTHRH2HRH1
SCHEMBL9390735 0.79 L3MBTL1 (0.74) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL7336231 0.78 THRA (0.57) THRATHRBHPGDHRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275028-A1 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof SIENA BIOTECH S.P.A. (IT) 2008-11-06 US disclosed
US-20080275028-A1 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof SIENA BIOTECH S.P.A. (IT) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275028-A1 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof CHRNA7, CHRNA5, CHRNA1 EPHX2 777/4885L3MBTL1 3654/4885GAA 1258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.